S&P 500 7,356.16 â–ŧ 9.30 (-0.13%) DOW 51,833.81 ▲ 166.97 (+0.32%) NASDAQ 25,470.02 â–ŧ 117.02 (-0.46%) US Markets Closed â€ĸ 10:44 PM ET

MDLN

Medline Inc.

Price Chart
Latest Quote

$36.05

+0.75 (+2.12%)
Current Price
Previous Close $35.30
Open $35.44
Day High $37.05
Day Low $35.30
Volume 6,574,516
Fetched: 2026-06-25T02:44:38
Stock Information
Shares Outstanding 845.61M
Total Debt $12.64B
Cash Equivalents $2.27B
Revenue $29.14B
Net Income $966.00M
Sector Healthcare
Industry Medical Instruments & Supplies
Market Cap $64.23B
P/E Ratio 31.62
EPS (TTM) $1.14
Exchange NMS
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$48.93B
Sales$29.14B
Income$966.00M
Book/sh$13.32
Cash/sh$2.68
Employees45K
Financial Ratios
Quick Ratio2.34
Current Ratio4.41
Debt/Eq65.31
EPS Growth TTM-59.90%
Returns & Margins
ROE6.05%
Gross Margin25.86%
Operating Margin5.43%
Profit Margin3.32%
Ownership
Insider Ownership0.21%
Institutional Ownership99.05%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E21.61
P/S2.20
P/B2.71
Analyst Data
Recommendationbuy
Target Price$51.15
Technical Indicators
SMA20$35.68
SMA50$39.69
RSI58.25
ATR1.5836
Shares Float356.91M
Short Float5.85%
Short Ratio1.96
Rel Volume0.54
Performance History
Week-2.80%
Month-2.59%
Quarter-14.23%
6 Months-13.45%
YTD-11.25%
10 Years-12.07%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-24 $36.05 6,574,516
2026-06-23 $35.30 5,580,800
2026-06-22 $34.71 6,692,600
2026-06-18 $35.94 15,306,400
2026-06-17 $36.42 10,830,300
2026-06-16 $37.09 8,557,700
2026-06-15 $37.33 15,055,900
2026-06-12 $36.61 12,484,400
2026-06-11 $37.13 9,480,300
2026-06-10 $36.54 9,245,600
2026-06-09 $36.01 10,167,900
2026-06-08 $33.80 8,719,300
2026-06-05 $33.61 7,570,500
2026-06-04 $34.45 13,274,200
2026-06-03 $34.47 15,578,100
2026-06-02 $33.19 18,085,400
2026-06-01 $35.75 13,611,200
2026-05-29 $36.56 33,130,000
2026-05-28 $36.80 16,940,500
2026-05-27 $35.84 7,470,200
2026-05-26 $36.16 14,710,400
About Medline Inc.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

📰 Latest News
ICUI or MDLN: Which Is the Better Value Stock Right Now?
Zacks â€ĸ 2026-06-18T15:40:03Z
Article thumbnail
Here is Why Medline (MDLN) is One of the Best Young Stocks with the Highest Upside Potential
Insider Monkey â€ĸ 2026-06-13T18:37:59Z
Article thumbnail
Is Medline (MDLN) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential?
Insider Monkey â€ĸ 2026-06-09T17:26:01Z
Article thumbnail
Healthcare Stocks Can Benefit From AI, Too. But That Isn’t the Reason to Buy Them.
Barrons.com â€ĸ 2026-06-06T20:38:00Z
Article thumbnail
FDA Warning Tests Medline Quality Systems And Earnings Story
Simply Wall St. â€ĸ 2026-06-06T14:08:48Z
Article thumbnail
Assessing Medline (MDLN) Valuation After Recent Share Price Pullback
Simply Wall St. â€ĸ 2026-05-25T19:07:16Z
Article thumbnail
Monashee Scales Back Its Bet on Structure Therapeutics
Motley Fool â€ĸ 2026-05-20T19:47:07Z
Article thumbnail
Stocks Rally as Crude Oil and Bond Yields Slump
Barchart â€ĸ 2026-05-20T15:17:22Z
Article thumbnail
Stocks Climb on Lower Bond Yields and Chipmaker Strength
Barchart â€ĸ 2026-05-20T14:14:30Z
Article thumbnail
Is Medline (MDLN) Offering Opportunity After Recent Share Price Pullback And DCF Estimate?
Simply Wall St. â€ĸ 2026-05-09T19:08:37Z
Article thumbnail
Period:
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $20,607,000,000 - - -
Cost Of Revenue $20,914,000,000 - - -
Total Revenue $28,432,000,000 - - -
Operating Revenue $28,432,000,000 - - -
Expenses
Interest Expense $812,000,000 - - -
Total Expenses $26,220,000,000 - - -
Other Income Expense $-152,000,000 - - -
Other Non Operating Income Expenses $-64,000,000 - - -
Net Non Operating Interest Income Expense $-812,000,000 - - -
Interest Expense Non Operating $812,000,000 - - -
Operating Expense $5,306,000,000 - - -
Other Operating Expenses $78,000,000 - - -
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $1,159,000,000 - - -
Net Interest Income $-812,000,000 - - -
Normalized Income $1,240,576,000 - - -
Net Income From Continuing And Discontinued Operation $1,159,000,000 - - -
Total Operating Income As Reported $2,212,000,000 - - -
Net Income Common Stockholders $1,159,000,000 - - -
Net Income $1,159,000,000 - - -
Net Income Including Noncontrolling Interests $1,157,000,000 - - -
Net Income Continuous Operations $1,157,000,000 - - -
Pretax Income $1,248,000,000 - - -
Operating Income $2,212,000,000 - - -
Depreciation Amortization Depletion Income Statement $704,000,000 - - -
Depreciation And Amortization In Income Statement $704,000,000 - - -
Amortization Of Intangibles Income Statement $704,000,000 - - -
Gross Profit $7,518,000,000 - - -
Per Share
Diluted EPS $-0.01 $0.66 $0.13 $-0.01
Basic EPS $-0.01 $0.66 $0.13 $-0.01
Other
Tax Effect Of Unusual Items $-6,424,000 - - -
Tax Rate For Calcs $0 - - -
Normalized EBITDA (Bullshit earnings) $3,159,000,000 - - -
Total Unusual Items $-88,000,000 - - -
Total Unusual Items Excluding Goodwill $-88,000,000 - - -
Reconciled Depreciation $1,011,000,000 - - -
EBITDA (Bullshit earnings) $3,071,000,000 - - -
EBIT $2,060,000,000 - - -
Diluted Average Shares $810,000,000 $1,827,634,640 $1,827,634,640 $1,827,634,640
Basic Average Shares $810,000,000 $1,827,634,640 $1,827,634,640 $1,827,634,640
Diluted NI Availto Com Stockholders $1,159,000,000 - - -
Minority Interests $2,000,000 $0 $0 -
Tax Provision $91,000,000 - - -
Gain On Sale Of Security $-88,000,000 - - -
Amortization $704,000,000 - - -
Selling General And Administration $4,524,000,000 - - -
Fetched: 2026-06-20
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31
Assets
Net Tangible Assets $-11,235,000,000 $-6,100,000,000 $-22,265,000,000
Total Assets $38,484,000,000 - -
Total Non Current Assets $27,805,000,000 - -
Other Non Current Assets $472,000,000 - -
Non Current Deferred Assets $583,000,000 $0 -
Non Current Deferred Taxes Assets $583,000,000 $0 -
Goodwill And Other Intangible Assets $21,972,000,000 - -
Other Intangible Assets $13,893,000,000 - -
Current Assets $10,679,000,000 - -
Other Current Assets $438,000,000 - -
Inventory $4,769,000,000 - -
Receivables $3,533,000,000 - -
Accounts Receivable $3,533,000,000 - -
Allowance For Doubtful Accounts Receivable $-152,000,000 - -
Gross Accounts Receivable $3,685,000,000 - -
Cash Cash Equivalents And Short Term Investments $1,939,000,000 - -
Cash And Cash Equivalents $1,939,000,000 - -
Debt
Net Debt $10,622,000,000 - -
Total Debt $12,627,000,000 - -
Long Term Debt And Capital Lease Obligation $12,484,000,000 - -
Long Term Debt $12,484,000,000 - -
Current Debt And Capital Lease Obligation $143,000,000 - -
Current Debt $77,000,000 - -
Other Current Borrowings $77,000,000 - -
Liabilities
Total Liabilities Net Minority Interest $19,198,000,000 - -
Total Non Current Liabilities Net Minority Interest $16,708,000,000 - -
Other Non Current Liabilities $4,224,000,000 - -
Current Liabilities $2,490,000,000 - -
Other Current Liabilities $808,000,000 - -
Payables And Accrued Expenses $1,539,000,000 - -
Interest Payable $144,000,000 - -
Payables $1,072,000,000 - -
Total Tax Payable $111,000,000 - -
Income Tax Payable $24,000,000 - -
Accounts Payable $961,000,000 - -
Equity
Common Stock Equity $10,737,000,000 $16,524,000,000 $55,000,000
Total Equity Gross Minority Interest $19,286,000,000 - -
Stockholders Equity $10,737,000,000 $16,524,000,000 $55,000,000
Gains Losses Not Affecting Retained Earnings $27,000,000 $16,158,000,000 -
Other Equity Adjustments $27,000,000 $16,158,000,000 -
Retained Earnings $-7,000,000 $0 -
Other Equity Interest - $366,000,000 -
Other
Ordinary Shares Number $812,000,000 $812,000,000 $799,799,804
Share Issued $812,000,000 $812,000,000 $799,799,804
Tangible Book Value $-11,235,000,000 $-6,100,000,000 $-22,265,000,000
Invested Capital $23,298,000,000 $33,018,000,000 $16,572,000,000
Working Capital $8,189,000,000 - -
Capital Lease Obligations $66,000,000 - -
Total Capitalization $23,221,000,000 - -
Minority Interest $8,549,000,000 $0 -
Additional Paid In Capital $10,717,000,000 $0 -
Capital Stock $0 $0 -
Common Stock $0 $0 -
Preferred Stock $0 $0 -
Current Capital Lease Obligation $66,000,000 - -
Current Accrued Expenses $467,000,000 - -
Goodwill $8,079,000,000 - -
Net PPE $4,778,000,000 - -
Finished Goods $4,021,000,000 - -
Raw Materials $748,000,000 - -
Total Partnership Capital - $16,395,000,000 $16,922,000,000
Limited Partnership Capital - $16,384,000,000 $16,734,000,000
Fetched: 2026-06-20
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31
Free Cash Flow
Free Cash Flow $1,297,000,000 - $1,410,000,000
Operating Activities
Operating Cash Flow $1,744,000,000 - -
Cash Flow From Continuing Operating Activities $1,744,000,000 - -
Operating Gains Losses $85,000,000 $22,000,000 $3,000,000
Investing Activities
Capital Expenditure $-447,000,000 - $-275,000,000
Investing Cash Flow $-474,000,000 - -
Cash Flow From Continuing Investing Activities $-474,000,000 - -
Net Other Investing Changes $-33,000,000 - $-21,000,000
Financing Activities
Repurchase Of Capital Stock $-2,003,000,000 - -
Issuance Of Capital Stock $7,048,000,000 $0 $0
Financing Cash Flow $399,000,000 - -
Cash Flow From Continuing Financing Activities $399,000,000 - -
Net Other Financing Charges $-36,000,000 - -
Cash Dividends Paid $-518,000,000 - -
Common Stock Dividend Paid $-518,000,000 - -
Net Common Stock Issuance $5,045,000,000 - -
Common Stock Issuance $7,048,000,000 $0 $0
Other
Repayment Of Debt $-11,840,000,000 - -
Issuance Of Debt $7,748,000,000 - -
Interest Paid Supplemental Data $944,000,000 - -
Income Tax Paid Supplemental Data $62,000,000 - -
End Cash Position $1,942,000,000 - -
Beginning Cash Position $250,000,000 - -
Effect Of Exchange Rate Changes $23,000,000 - -
Changes In Cash $1,669,000,000 - -
Common Stock Payments $-2,003,000,000 - -
Net Issuance Payments Of Debt $-4,092,000,000 - -
Net Long Term Debt Issuance $-4,092,000,000 - -
Long Term Debt Payments $-11,840,000,000 - -
Long Term Debt Issuance $7,748,000,000 - -
Net Business Purchase And Sale $6,000,000 - -
Sale Of Business $6,000,000 - -
Net PPE Purchase And Sale $-447,000,000 - -
Purchase Of PPE $-447,000,000 - $-275,000,000
Change In Working Capital $-783,000,000 - $199,000,000
Change In Other Current Liabilities $-19,000,000 $-88,000,000 $-24,000,000
Change In Other Current Assets $-126,000,000 - -
Change In Payables And Accrued Expense $-19,000,000 $168,000,000 -
Change In Accrued Expense $-92,000,000 $62,000,000 -
Change In Payable $73,000,000 - -
Change In Account Payable $73,000,000 - -
Change In Inventory $-264,000,000 - -
Change In Receivables $-355,000,000 - -
Changes In Account Receivables $-355,000,000 - -
Other Non Cash Items $144,000,000 $121,000,000 $212,000,000
Stock Based Compensation $76,000,000 - -
Provisionand Write Offof Assets $54,000,000 - -
Depreciation Amortization Depletion $1,011,000,000 - -
Depreciation And Amortization $1,011,000,000 - -
Gain Loss On Investment Securities $-41,000,000 - -
Net Foreign Currency Exchange Gain Loss $68,000,000 - -
Net Income From Continuing Operations $1,157,000,000 - -
Fetched: 2026-06-20